EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The addition of peri-operative gentamicin with ciprofloxacin reduces infection and sepsis rates post transrectal prostate biopsy

Arjun Guduguntla, Andrew Xu, Kieran W Benn, Prassannah Satasivam

Prostate International · 2025-06 · 13 (2) · 90-95

DOI: 10.1016/j.prnil.2024.11.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prostate International, 2025-06. Verfasst von Arjun Guduguntla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Northern Health, Victoria, Australia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Despite the advent of transperineal (TP) biopsy and reduced risk of infective complications, transrectal ultrasound-guided (TRUS) prostate biopsy is still widely performed worldwide. The accepted prophylactic antibiotic is usually a single agent oral fluoroquinolone; however, this approach is beset by growing antibiotic resistance. The aim of this study was to assess whether the addition of intravenous gentamicin (2 mg/kg or at least 160 mg), immediately prior to biopsy, in conjunction with routine ciprofloxacin prophylaxis, reduced infection and sepsis rates post TRUS biopsy.

Method

Six hundred fifty-eight patients underwent TRUS biopsy at our center from 2017 to 2022, of whom 648 had data sufficient for analysis. We performed a retrospective analysis focusing on patient demographics (age, BMI, diabetes status), biopsy parameters, and outcomes of sepsis and urinary tract infection . Patients were recorded as developing sepsis if they required hospital admission for intravenous antibiotics. Fisher's exact test was employed for categorical variables, while the Student's t test was utilized for continuous variables for statistical significance.

Results

The rate of sepsis was 3.9% in the ciprofloxacin-only group, versus 0% in the ciprofloxacin plus gentamicin group (P value = 0.03). Overall aggregated post-TRUS infection rates was also 0% in the ciprofloxacin plus gentamicin group (P value = 0.005). We found no associated between infection and secondary risk factors.

Conclusion

The administration of 2 mg/kg intravenous gentamicin with oral ciprofloxacin prophylaxis reduces infection and sepsis rates post TRUS biopsy.

Schlagwörter

Stichwörter der Autor:innen

Antibiotic prophylaxisProstate biopsyProstate cancerTransperineal biopsyTransrectal ultrasound-guided biopsy

Autor:innen und Institutionen

  • Department of Urology, Northern Health, Victoria, Australia.
  • School of Medicine, University of Melbourne, Victoria, Australia.

Zitieren

APA

Guduguntla, A., Xu, A., Benn, K. W., & Satasivam, P. (2025). The addition of peri-operative gentamicin with ciprofloxacin reduces infection and sepsis rates post transrectal prostate biopsy. Prostate International, 13(2), 90-95. https://doi.org/10.1016/j.prnil.2024.11.006

Vancouver

Guduguntla A, Xu A, Benn KW, Satasivam P. The addition of peri-operative gentamicin with ciprofloxacin reduces infection and sepsis rates post transrectal prostate biopsy. Prostate International. 2025;13(2):90-95. doi:10.1016/j.prnil.2024.11.006

BibTeX
@article{Guduguntla2025,
  author = {Guduguntla, Arjun and Xu, Andrew and Benn, Kieran W and Satasivam, Prassannah},
  title = {The addition of peri-operative gentamicin with ciprofloxacin reduces infection and sepsis rates post transrectal prostate biopsy},
  journal = {Prostate International},
  year = {2025},
  volume = {13},
  number = {2},
  pages = {90--95},
  doi = {10.1016/j.prnil.2024.11.006}
}
Kostenlos starten →